In this episode, obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Robert Kushner, highlighted speaker from the Overcoming Obesity 2021 Conference, about The Semaglutide Treatment Effect in People with Obesity (STEP) Trials. Topics covered include the results of the four STEP trails, obstacles to treating obesity, new obesity treatments in the pipeline, and the opportunities for increasing obesity education for future clinicians.
You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts.
Episode Guest
Nicholas Pennings, DO, FOMA, Dipl. ABOM
Resources Mentioned
Episode Description n this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA Dipl. ABOM and Sandra Christensen, MNS, ARNP, FOMA, discuss a recent...
In episode four of our four-part Advocacy series, Dr. Nicholas Pennings, an Obesity Medicine Specialist and Clinical Education Director at OMA, engages in a...
In this episode, Obesity medicine specialist and OMA clinical education director, Dr. Nicholas Pennings interviews Dr. Nikhil Dhurandhar, highlighted speakers from Obesity Medicine 2021...